维普中文期刊产品整合服务
20篇 您的检索式:作者名="Callus A"
    题名 作者 年代 出处 被引量
1Tensile properties and failure mechanisms of 3D woven GRP composites 显示文摘Callus P J Mouritz A P Bannister M K 1999Composites Part A1999,30,11:1
2Tensile propertiesand failure mechanisms of 3D woven GRP composites显示文摘CALLUS P J MOURITZ A P BANNISTER M K 1999Composites Part A:Applied Science and Manufacturing1999,30,11:1
3Tensile properties and failure mechanisms of 3D woven GRP composites显示文摘CALLUS P J MOURITZ A P BANNISTER M K 1999Compos A Appl Sci Manuf1999,30,11:1
4Tensile properties and failure mechanisms of 3d woven Grp composites显示文摘CALLUS P J MOURITZ A P BANNISTER M K 1999Composites Part a-Applied Science and Manufacturing1999,30,11:1
5Apixaban or enoxaparin for thromboprophylaxis after knee replacement显示文摘Lassen MR Raskob GE Callus A 2009N Engl J Med2009,361,6:1
6Oral anticoagulant thera- py: antithrombotic therapy and prevention of thrombosis, 9th ed: A- merican college of chest physicians evidence - based clinical practice guidelines显示文摘Ageno W Callus AS Wittkowsky A 2012Chest2012,141,:1
7显示文摘Mariotti D A rcioni &Callus culture of Coronilla varia L 1983Plant Cell Tissue Organ Culture1983,,2:1
8Oral anticoagulant therap y:antithrombotic therapy and prevention of thrombosis,9th ed:american college of chest physicians evidence-based clinical practice guidelines显示文摘Ageno W Callus AS Wittkowsky A 2012Chest2012,141,2:1
9Tensile properties and failure mechanisms of 3D woven GRP composites 显示文摘Callus P J Mouritz A P Bannister M K 1999Composites Part A: Applied Science and Manufacturing1999,30,11:1
10Risk factor for breast cancer in women under 40 years显示文摘Tavani A Callus S La-Vecchia C 1999Eur J Cancer1999,35,9:1
11Tensile properties and failure mechanisms of 3D woven GRP composites显示文摘CALLUS P MOURITZ A P BANNISTER M K etal 1999Composites Part a-applied science and manufacturing1999,30,11:1
12Risk tnctors tor focalnodutar hy- perplasia of the liver: ,an Italian case - control study 显示文摘Scalori A 'lavaai A Callus S 2002Am J Gastro- enterol2002,97,9:1
13Caspase inhibitors & Viral, cellu- lar and ehemical显示文摘CALLUS B A VAUX D L 2007Cell Death and Differentiation2007,14,1:1
14Cytoplasmic p53 is not required for PUMA induced apoptosis显示文摘Callus B A Ekert P G Heraud J E Jabbour A M Kotevski A Vince J E 2008Cell Death Differ2008,15,:1
15Tensile properties and failure mechanisms of 3D woven GRP composites显示文摘CALLUS P J MOURITZ A P BANNISTE M K 1999Composites Part A: Applied Science and Manufacturing1999,30,11:1
16Caspase inhibitors: viral, cellular and chemical显示文摘Callus B A Vaux D L 2007Cell Death and Differentiation2007,14,:1
17Tensile properties and failure mechanisms of 3D woven GRP composites显示文摘CALLUS P J MOURITZ A P BANNISTER M K 1999Compos Part A1999,30,:1
18Tensile properties and failure mechanisms of 3D woven GRP composites显示文摘 Mouritz A P Banniste M K 1999Composites Part A:Applied Science and Manufacturing1999,30,11:1
19Cytoplasmic p53 is not required for PUMA-induced apoptosis 显示文摘Callus B A Ekert P G Heraud J E 2008Cell Death Differ2008,15,1:1
20Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxa- ban (BAY 59-7939) : the ODIXa-DVT (Oral Direct Factor Xa Inhibi- tor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study显示文摘Agnelli G Callus A Goldhaber SZ 2007Circulation2007,116,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费